Astellas Pharma Inc. (ALPMY) on Tuesday reported results from a post hoc analysis of its GATHER1 and GATHER2 pivotal studies, showing that treatment with IZERVAY reduced the risk of patients progressing to loss of driving eligibility compared with sham over 24 months in geographic atrophy (GA) associated...
VistaGen Therapeutics Inc (VTGN) on Tuesday announced preliminary positive data from the ongoing open-label extension portion of its Phase 3 PALISADE-3 study evaluating fasedienol for the acute treatment of social anxiety disorder. The study assessed changes from baseline on the Liebowitz Social Anxiety...
Tuesday, Alkermes plc (ALKS) announced positive topline results from the REVITALYZ phase 3 study, evaluating the investigational use of LUMRYZ extended-release oral suspension in adults with idiopathic hypersomnia. The company stated that LUMRYZ met the primary endpoint by showing statistically significant...
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.